TANYA TREWICK - RYANS: Open Payments
NPI 1689056343 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,443 in 16 payments from 14 companies in 2025. Trend: 2023 $582 · 2024 $1,234 · 2025 $1,443
Food & beverage: $1,443
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 2 | $136 |
| Neurocrine BioSciences, Inc. | 1 | $128 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Dexcom, Inc. | 1 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $113 |
| Insulet Corporation | 1 | $113 |
| Phathom Pharmaceuticals, Inc. | 1 | $101 |
| Amgen Inc. | 1 | $101 |
Products named: FANAPT, INGREZZA, LUMRYZ, REXULTI, AUSTEDO XR, DEXCOM G7 GSS (161), OMNIPOD, VOQUEZNA.
Industry payments across DE — which companies pay providers there.
